Lilly Res Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LILLY RES LABS, and what generic and branded alternatives to LILLY RES LABS drugs are available?
LILLY RES LABS has one approved drug.
Drugs and US Patents for Lilly Res Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly Res Labs | DYNABAC | dirithromycin | TABLET, DELAYED RELEASE;ORAL | 050678-001 | Jun 19, 1995 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.